Greenway Medical merger: Greenway Medical Technologies, Inc. (NYSE:GWAY) recently entered into a merger agreement, according to a filing from one of its shareholders, Pamlico Capital, which holds 17.8% of its shares. Under the terms of the agreement VCG Holdings and Crestview Acquisition Corp will purchase all of the outstanding shares of Greenway Medical Technologies for a price of $20.35 per share.
Pamlico Capital owns 5.3 million shares of Greenway Medical Technologies, with the value of the stake amounting to $107.8 million. For its fiscal year ended June 30, Greenway Medical reported a net loss of $5.1 million, versus an income of $2.9 million in the previous fiscal year. For FY2014, the company forecasted a net loss between $6.3 million and $5 million, Greenway said in a statement.
In addition to Pamlico, some hedge funds also disclosed ownership of Greenway Medical Technologies in the latest round of 13F filings. As follows, CR Intrinsic Investors, an SAC Capital Subsidiary, owned 307,300 shares, followed by Chuck Royce’s Royce & Associates with 150,000 shares, and D. E. Shaw’s D. E .Shaw & Co. Check back here for more updates on the Greenway Medical merger.